Literature DB >> 32706139

Triple pelvic osteotomy with a 12.5° and a 20° Slocum-type plate: A short-term prospective clinical pilot study in 38 dogs.

Luc A A Janssens1, Robert Daems2, Lorenzo Pillin3, Peter Vandekerckhove2, Stefan Van Dongen4.   

Abstract

OBJECTIVE: To determine whether using 12.5° Slocum-like triple pelvic osteotomy (TPO) plates would create sufficient femoral head coverage and lower the occurrence of overrotation compared with using 20° TPO plates in dogs with hip dysplasia. STUDY
DESIGN: Prospective clinical study. SAMPLE POPULATION: Thirty-five dogs with hip dysplasia (38 hips).
METHODS: Nineteen hips were surgically treated with a custom-made Slocum-type 12.5° TPO plate, and these were matched to 19 hips surgically treated with a 20° commercial Slocum TPO plate. Hips were case matched according to size and breed. Ortolani sign, angles of subluxation and reduction, distraction index, and femoral head coverage (FHC) were compared between groups. Excessive coverage was defined as >80%.
RESULTS: In the 12.5° group, FHC was ≥50% in all hips, with mean FHC (67%), gain (37%), and excessive coverage (11%) all significantly less than in the 20° group (79%, 54%, and 42%, respectively).
CONCLUSION: The 12.5° plate produced sufficient FHC compared with the 20° plate, with fewer hips with excessive coverage. CLINICAL SIGNIFICANCE: The 12.5° TPO plate may result in sufficient FHC with a lower occurrence of excessive coverage compared with 20° plates.
© 2020 The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2020        PMID: 32706139     DOI: 10.1111/vsu.13471

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  1 in total

1.  The Use of Sixty Degree Rotation of the Acetabulum for Treatment of Dogs With Canine Hip Dysplasia. A Short Case Series.

Authors:  Horia Elefterescu; Ciprian Andrei Ober; Andrei Timen; Christos Yiapanis; William McCartney; Joshua Milgram
Journal:  Front Vet Sci       Date:  2021-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.